Ultrasensitive study of gatifloxacin based on its enhancing effect on the cerium (IV)-sodium hyposulfite chemiluminescence reaction in a micellar medium.
A sensitive and rapid flow-injection chemiluminescence (CL) method has been developed for the determination of gatifloxacin in pharmaceutical preparations and biological samples. The method is based on the enhancing effect of gatifloxacin on CL emission generated by the interaction of Ce (IV) in sulphuric acid and sodium hyposulphite (Na(2)S(2)O(4)) sensitized by sodium dodecyl benzene sulfonate (SDBS). Strong CL emission was observed when gatifloxacin was injected into the Ce (IV) in sulphuric acid and Na(2)S(2)O(4) solution incorporated with SDBS in a flow-cell. Several experimental parameters affecting the CL reaction were investigated and optimized systematically. Under the optimum conditions, it was found that the CL intensity is proportional to the concentration of gatifloxacin in the range of 1.12 × 10(-11)-4.40 × 10(-9) g mL(-1) with a co-relation coefficient of 0.9994. The limit of detection was found to be 4.87 × 10(-12) g mL(-1) and the relative standard deviation (RSD, n=7) was 1.8% for 4 × 10(-8) g mL(-1) of GFLX. The proposed method offers higher sensitivity, wide linear range and better stability without requiring sophisticated instrumentation. Thus, the proposed method has been successfully applied to the determination of gatifloxacin in pharmaceuticals, serum and human urine.
Department of Chemistry, Kyungpook National University, Daegu 702-701, South Korea.
Mohammad
M
Kamruzzaman
Al-Mahmnur
AM
Alam
Taslima
T
Ferdous
Sang Hak
SH
Lee
Young Ho
YH
Kim
Sung Hong
SH
Kim
D002563:Cerium / Q000737:chemistry*; D017022:Flow Injection Analysis; D024841:Fluoroquinolones / Q000032:analysis*; D000077734:Gatifloxacin; D006801:Humans; D007700:Kinetics; D049449:Luminescence; D008823:Micelles; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry; D012016:Reference Values; D012964:Sodium / Q000737:chemistry*; D013050:Spectrometry, Fluorescence; D013447:Sulfites / Q000737:chemistry*
D024841:Fluoroquinolones; D008823:Micelles; D004364:Pharmaceutical Preparations; D013447:Sulfites; D002563:Cerium; D012964:Sodium; D000077734:Gatifloxacin
Clin Infect Dis. 2000 Aug;31 Suppl 2:S51-8
10984329
Luminescence. 2001 May-Jun;16(3):213-35
11400260
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 15;810(1):77-83
15358310
J Pharm Biomed Anal. 2006 Apr 11;41(1):251-5
16311002
Spectrochim Acta A Mol Biomol Spectrosc. 2009 May;72(4):766-71
19117794
J Pharm Biomed Anal. 2005 Feb 23;37(2):327-32
15708674
Luminescence. 2008 Jan-Feb;23(1):7-13
18175292
Anal Sci. 2006 May;22(5):743-5
16770055
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5;798(1):167-73
14630373
Drugs. 2002;62(1):169-207
11790160
Talanta. 2005 Aug 15;67(2):354-9
18970175
Clin Infect Dis. 2003 Nov 1;37(9):1210-5
14557966
Anal Bioanal Chem. 2004 Dec;380(7-8):918-23
15568139
Spectrochim Acta A Mol Biomol Spectrosc. 2007 Aug;67(5):1306-12
17113819
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Feb;69(2):478-82
17576092
Spectrochim Acta A Mol Biomol Spectrosc. 2010 Jan;75(1):334-9
19939728